EP Wealth Advisors LLC Buys New Position in CVS Health Corporation $CVS

EP Wealth Advisors LLC bought a new position in CVS Health Corporation (NYSE:CVS) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 74,542 shares of the pharmacy operator’s stock, valued at approximately $7,711,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of CVS. Caitong International Asset Management Co. Ltd increased its stake in shares of CVS Health by 407.2% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 281 shares in the last quarter. Swiss RE Ltd. acquired a new stake in CVS Health in the fourth quarter worth $26,000. Kilter Group LLC bought a new stake in CVS Health in the second quarter valued at $27,000. Sankala Group LLC acquired a new position in shares of CVS Health during the fourth quarter valued at about $28,000. Finally, Global Trust Asset Management LLC boosted its position in shares of CVS Health by 344.8% during the 1st quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 300 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Down 0.7%

CVS opened at $93.01 on Friday. CVS Health Corporation has a fifty-two week low of $69.51 and a fifty-two week high of $110.68. The firm has a market capitalization of $118.96 billion, a P/E ratio of 24.61, a PEG ratio of 0.85 and a beta of 0.61. The company’s 50-day moving average is $102.02 and its 200 day moving average is $88.86. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. The business had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Research analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were issued a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 annualized dividend and a dividend yield of 2.9%. CVS Health’s dividend payout ratio is currently 70.37%.

Wall Street Analysts Forecast Growth

CVS has been the subject of several research reports. Barclays raised their target price on CVS Health from $106.00 to $108.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Truist Financial increased their price target on CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Piper Sandler restated an “overweight” rating and set a $113.00 price objective on shares of CVS Health in a report on Monday, June 1st. Bank of America upped their target price on CVS Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Monday, June 22nd. Finally, TD Cowen lifted their price target on shares of CVS Health from $105.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, May 11th. Twenty-two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $107.17.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.